Lexogen Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Lexogen General Information

Description

Developer of profiling technologies designed to offer a detailed analysis of the complete transcriptome and individual full-length RNAs of interest. The company's technology specializes in developing RNA-Seq library preparation kits, RNA analysis, and RNA-Seq data analysis software, enabling clients and scientists to perform various research and development processes.

Contact Information

Website
www.lexogen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Campus Vienna Biocenter 5
  • Vienna, 1030
  • Austria
+43 01
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Campus Vienna Biocenter 5
  • Vienna, 1030
  • Austria
+43 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lexogen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Jun-2026 Completed Generating Revenue
4. Later Stage VC Completed Generating Revenue
3. Seed Round 01-Oct-2011 Completed Generating Revenue
2. Accelerator/Incubator 01-Aug-2007 Completed Startup
1. Seed Round 01-Jan-2007 Completed Startup
To view Lexogen’s complete valuation and funding history, request access »

Lexogen Patents

Lexogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021354916-A1 Method and means for generating transcribed nucleic acids Pending 02-Oct-2020
CA-3193967-A1 Method and means for generating transcribed nucleic acids Pending 02-Oct-2020
EP-3978626-A1 Method and means for generating transcribed nucleic acids Inactive 02-Oct-2020
EP-4222284-A1 Method and means for generating transcribed nucleic acids Pending 02-Oct-2020
US-20230348963-A1 Method and means for generating transcribed nucleic acids Pending 02-Oct-2020 C12Q1/6869
To view Lexogen’s complete patent history, request access »

Lexogen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lexogen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avv Investment Venture Capital Minority
To view Lexogen’s complete investors history, request access »

Lexogen FAQs

  • When was Lexogen founded?

    Lexogen was founded in 2007.

  • Where is Lexogen headquartered?

    Lexogen is headquartered in Vienna, Austria.

  • What is the size of Lexogen?

    Lexogen has 60 total employees.

  • What industry is Lexogen in?

    Lexogen’s primary industry is Biotechnology.

  • Is Lexogen a private or public company?

    Lexogen is a Private company.

  • What is Lexogen’s current revenue?

    The current revenue for Lexogen is .

  • Who are Lexogen’s investors?

    Avv Investment has invested in Lexogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process